Prot# TMC125-C214: Early Access of TMC125 in Combination with Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects with Limited Treatment Options

Project: Research project

Project Details

StatusFinished
Effective start/end date3/15/07 → 3/15/10

Funding

  • Ingenix Pharmaceutical Services, Inc. (TMC125-C214)
  • Tibotec Pharmaceuticals Ltd. (TMC125-C214)